In your stateKansas
In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.
Economic Impact In Your State: Kansas
$6.9B
Total output supported by biophamaceutical sector
$549,650
Total output supported by biophamaceutical sector
27,593
Total Jobs
5,805
Direct Jobs
Clinical Trials in Your State: Kansas
535
TOTAL CLINICAL TRIALS
$245.4 million
INVESTED IN CLINICAL TRIALS
13,255
TOTAL ECONOMIC IMPACT OF CLINICAL TRIAL INVESTMENTS
$628.4 million
INVESTED IN CLINICAL TRIALS
Programs and Initiatives in Your State: Kansas
State programs and initiatives to promote biopharmaceutical industry development
- ACCELERATING INNOVATION, COMMERCIALIZATION & ENTREPRENEURIAL DEVELOPMENT
BUILDING RESEARCH CAPACITY AND/OR R&D INFRASTRUCTURE
ECONOMIC INNOVATION INCENTIVES
STEM EDUCATION & WORKFORCE DEVELOPMENT
TARGETED STRATEGIES
VENTURE FINANCING